Susan Nmn Ungar

Array ( [id] => 3824581 [patent_doc_number] => 05783397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Screening natural samples for new therapeutic compounds using capillary electrophoresis' [patent_app_type] => 1 [patent_app_number] => 8/662085 [patent_app_country] => US [patent_app_date] => 1996-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 33 [patent_no_of_words] => 7703 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783397.pdf [firstpage_image] =>[orig_patent_app_number] => 662085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220986 [patent_doc_number] => 06010865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Process for detecting a variant CD44 gene product' [patent_app_type] => 1 [patent_app_number] => 8/564225 [patent_app_country] => US [patent_app_date] => 1996-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 45 [patent_no_of_words] => 11985 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010865.pdf [firstpage_image] =>[orig_patent_app_number] => 564225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920757 [patent_doc_number] => 05876711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Methods and compositions for determining the tumor suppressor status of cells' [patent_app_type] => 1 [patent_app_number] => 8/657828 [patent_app_country] => US [patent_app_date] => 1996-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8597 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876711.pdf [firstpage_image] =>[orig_patent_app_number] => 657828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044709 [patent_doc_number] => 05908761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Galectin-8 and galectin-8-like proteins and DNA molecules coding therefor' [patent_app_type] => 1 [patent_app_number] => 8/647960 [patent_app_country] => US [patent_app_date] => 1996-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 12703 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908761.pdf [firstpage_image] =>[orig_patent_app_number] => 647960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051564 [patent_doc_number] => 05969107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor' [patent_app_type] => 1 [patent_app_number] => 8/653402 [patent_app_country] => US [patent_app_date] => 1996-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 12566 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969107.pdf [firstpage_image] =>[orig_patent_app_number] => 653402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416831 [patent_doc_number] => 06224865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Suppression of inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/583129 [patent_app_country] => US [patent_app_date] => 1996-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19235 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/224/06224865.pdf [firstpage_image] =>[orig_patent_app_number] => 583129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3708116 [patent_doc_number] => 05654406 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Antibody to ERBB2 promoter binding factor' [patent_app_type] => 1 [patent_app_number] => 8/645865 [patent_app_country] => US [patent_app_date] => 1996-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16851 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654406.pdf [firstpage_image] =>[orig_patent_app_number] => 645865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644722 [patent_doc_number] => 07118741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Transepithelial transport of molecular species' [patent_app_type] => utility [patent_app_number] => 08/952707 [patent_app_country] => US [patent_app_date] => 1996-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4220 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118741.pdf [firstpage_image] =>[orig_patent_app_number] => 08952707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173301 [patent_doc_number] => 06140464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Nonapeptides that bind a HLA-A2.1 molecule' [patent_app_type] => 1 [patent_app_number] => 8/644116 [patent_app_country] => US [patent_app_date] => 1996-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9014 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140464.pdf [firstpage_image] =>[orig_patent_app_number] => 644116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173724 [patent_doc_number] => 06036950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Method for improving utilisation of nutrients by ruminant or ruminant-like animals' [patent_app_type] => 1 [patent_app_number] => 8/633776 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 2814 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036950.pdf [firstpage_image] =>[orig_patent_app_number] => 633776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3748270 [patent_doc_number] => 05717073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Anti-gp130 monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/634736 [patent_app_country] => US [patent_app_date] => 1996-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4506 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/717/05717073.pdf [firstpage_image] =>[orig_patent_app_number] => 634736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290778 [patent_doc_number] => 06180377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Humanized antibodies' [patent_app_type] => 1 [patent_app_number] => 8/569147 [patent_app_country] => US [patent_app_date] => 1996-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 12932 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180377.pdf [firstpage_image] =>[orig_patent_app_number] => 569147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156150 [patent_doc_number] => 06124436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Purified mammalian monocyte antigens and related reagents' [patent_app_type] => 1 [patent_app_number] => 8/600430 [patent_app_country] => US [patent_app_date] => 1996-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18475 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124436.pdf [firstpage_image] =>[orig_patent_app_number] => 600430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758977 [patent_doc_number] => 05741635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Method of quantitating GTP and GDP bound to a G protein and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/593614 [patent_app_country] => US [patent_app_date] => 1996-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9714 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741635.pdf [firstpage_image] =>[orig_patent_app_number] => 593614 [rel_patent_id] =>[rel_patent_doc_number] =>)